Xcell Therapeutics Inc. (KOSDAQ:373110)
South Korea
· Delayed Price · Currency is KRW
1,415.00
+64.00 (4.74%)
Mar 10, 2026, 3:30 PM KST
Xcell Therapeutics Ratios and Metrics
Market cap in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
| Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Mar '26 Mar 9, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Market Capitalization | 23,365 | 44,384 | - | - | - | - | |
| Enterprise Value | 28,511 | 38,298 | - | - | - | - | |
| Last Close Price | 1351.00 | 3373.54 | - | - | - | - | |
| PS Ratio | 17.15 | 22.95 | - | - | - | - | |
| PB Ratio | 14.40 | 4.87 | - | - | - | - | |
| P/TBV Ratio | 26.30 | 5.17 | - | - | - | - | |
| EV/Sales Ratio | 20.93 | 19.80 | - | - | - | - | |
| Debt / Equity Ratio | 3.93 | 0.63 | 2.73 | 0.69 | 0.38 | 3.54 | |
| Net Debt / Equity Ratio | 3.17 | -0.34 | 2.16 | 0.03 | -0.52 | -1.27 | |
| Net Debt / EBITDA Ratio | -0.61 | 0.40 | -0.70 | -0.04 | 1.80 | 0.46 | |
| Net Debt / FCF Ratio | -0.56 | 0.42 | -0.73 | -0.03 | 1.42 | 0.31 | |
| Asset Turnover | 0.09 | 0.14 | 0.09 | 0.05 | 0.10 | 0.05 | |
| Inventory Turnover | 2.17 | 4.44 | 4.01 | 4.67 | 3.87 | 2.48 | |
| Quick Ratio | 0.30 | 1.90 | 0.36 | 1.19 | 2.83 | 1.18 | |
| Current Ratio | 0.68 | 2.14 | 0.52 | 1.39 | 2.93 | 1.29 | |
| Return on Equity (ROE) | -154.65% | -165.90% | -170.80% | -67.53% | -102.65% | - | |
| Return on Assets (ROA) | -42.33% | -42.63% | -43.01% | -26.46% | -18.88% | -26.46% | |
| Return on Capital Employed (ROCE) | -210.90% | -77.90% | -177.90% | -80.40% | -30.90% | -55.60% | |
| Earnings Yield | -42.84% | -21.50% | - | - | - | - | |
| FCF Yield | -39.69% | -16.63% | - | - | - | - | |
| Buyback Yield / Dilution | -14.60% | -13.14% | -1.02% | -5.71% | -364.87% | -3.12% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.